Clarke-Pearson DL - Search Results

1

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.

Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC Jr, Berchuck A. Lukes AS, et al. Cancer. 1994 May 1;73(9):2380-5. doi: 10.1002/1097-0142(19940501)73:9<2380::aid-cncr2820730922>3.0.co;2-g. Cancer. 1994. PMID: 7909491

2

Ploidy analysis of epithelial ovarian cancers using image cytometry.

Berchuck A, Boente MP, Kerns BJ, Kinney RB, Soper JT, Clarke-Pearson DL, Bast RC Jr, Bacus SS. Berchuck A, et al. Gynecol Oncol. 1992 Jan;44(1):61-5. doi: 10.1016/0090-8258(92)90013-9. Gynecol Oncol. 1992. PMID: 1370427

3

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

4

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease.

Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):15-21. doi: 10.1016/0002-9378(91)90615-x. Am J Obstet Gynecol. 1991. PMID: 1670908

5

Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma.

Kohler MF, Soper JT, Tucker JA Jr, Clarke-Pearson DL. Kohler MF, et al. Cancer. 1991 Sep 15;68(6):1380-3. doi: 10.1002/1097-0142(19910915)68:6<1380::aid-cncr2820680633>3.0.co;2-u. Cancer. 1991. PMID: 1831399

6

Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.

Soper JT, Berchuck A, Clarke-Pearson DL. Soper JT, et al. Cancer. 1991 Aug 15;68(4):725-9. doi: 10.1002/1097-0142(19910815)68:4<725::aid-cncr2820680410>3.0.co;2-1. Cancer. 1991. PMID: 1855171

7

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, et al. Berchuck A, et al. Cancer Res. 1990 Jul 1;50(13):4087-91. Cancer Res. 1990. PMID: 1972347

8

Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.

Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Obstet Gynecol. 1990 Sep;76(3 Pt 1):381-7. Obstet Gynecol. 1990. PMID: 1974342

9

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1991 Feb;164(2):669-74. doi: 10.1016/s0002-9378(11)80044-x. Am J Obstet Gynecol. 1991. PMID: 1992720

10

Overexpression and mutation of p53 in epithelial ovarian cancer.

Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A. Marks JR, et al. Cancer Res. 1991 Jun 1;51(11):2979-84. Cancer Res. 1991. PMID: 2032235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters